Tia D. Fenton
Partner
Tel (703) 413-2777

Tia D. Fenton

Partner

Tia D. Fenton, a skilled patent litigation lawyer, is a partner in the firm's Litigation and ITC Litigation practice groups.  With a background in chemistry, biochemistry and genetics, she has a deep understanding of the sciences and technologies involved in her clients’ chemical, biochemical, biomedical and pharmaceutical inventions.

In addition to litigating cases in district court and before the Federal Circuit, Ms. Fenton advises her clients on litigation procedure and strategies, litigation avoidance, and the overall protection of patent portfolios. Ms. Fenton also has experience in patent interference proceedings and prosecution-related matters in the chemical arts, including the revival of abandoned patent applications.

Prior to attending law school, Ms. Fenton worked as a Forensic DNA Analyst at Cellmark Diagnostics, Inc., and as a Forensic DNA Examiner at the Department of Defense's Armed Forces DNA Identification Laboratory. She also served as an expert witness in DNA identification testing for approximately four years, testifying in at least 20 trials throughout the country. Ms. Fenton’s trial and testimony experience provides her with a unique perspective on litigation, including particular skill in preparing expert witnesses for depositions and trial.

Ms. Fenton also has experience lecturing scientists and graduate students on the presentation and effective use of scientific and technical evidence in the courtroom.

Representative Matters

Represented AFG (now known as AGC Flat Glass North America) and Asahi Glass in a case involving thin film low-emissivity coatings. AFG and Asahi Glass v. Cardinal IG, (E.D. Tenn. 2005).

Represented SMC Corp. in an ITC action involving connectors used in pneumatic control systems. In the Matter of Certain Connecting Devices for Use with Modular Compressed Air Conditioning Units, Including Filters, Regulators, and Lubricators.

Represented Senju, Kyorin and Allergan in a case involving an antibiotic ophthalmic pharmaceutical formulation. Senju Pharm. Co., Ltd., Kyorin Pharm. Co., Ltd. and Allergan, Inc. v. Apotex Inc. and Apotex Corp.

Represented Solvay in a case involving a process for making hydrofluorocarbons. Solvay S.A. v. Honeywell International Inc.

Represented Zambon in a case involving a neuropathic drug. Zambon Group S.p.A. v. Teva Pharmaceutical Industries.

Monday, April 23, 2012

The Federal Circuit recently issued a precedential opinion in General Electric Co. v. ITC, 670 F.3d 1206 (Fed. Cir. 2012).  See our March 1, 2012 post.  In this opinion, the Court addressed its 1984 decision in ...

Thursday, December 01, 2011

On November 29, 2011, ALJ Robert K. Rogers, Jr. issued Order No. 23 in Certain Muzzle-Loading Firearms and Components Thereof (Inv. No. 337-TA-777).  The Order granted-in-part and denied-in-part a motion filed by Respondents Blackpowder Products Inc. and...